2nd April, 2008:
SciGen Limited (ASX:SIE) announces that it has entered into a product licensing and distribution agreement pursuant to which SciGen Ltd. will procure governmental approvals for the importation, distribution, marketing, and sale of
Generex’s Oral-lyn™,
the Company’s proprietary oral insulin spray product, in the People’s Republic of China, Hong Kong, and the following additional countries : Indonesia, South Korea, Malaysia, the Philippines, Singapore, Thailand, and Vietnam...
[PDF] SciGen's Press Release -
Generex’s Press release -
